Phenylephrine increases T wave shock energy required to induce ventricular fibrillation

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Experimental models suggest phenylephrine alters cardiac neural tone and ventricular fibrillation threshold (VFT).
• Understanding phenylephrine's effect on VFT in humans is crucial for managing cardiac arrhythmias.

Purpose of the Study:

• To investigate if phenylephrine increases the energy required to induce ventricular fibrillation (VF) in humans.
• To assess the impact of phenylephrine on VFT during T-wave shock induction.

Main Methods:

• Prospective study involving 18 patients with implanted cardioverter-defibrillators.
• VF was induced using titrated DC monophasic T-wave shocks.
• Phenylephrine infusion randomized to increase systolic blood pressure by >20 mmHg.

Main Results:

• Mean energy to induce VF increased from 1.1 J to 1.7 J during phenylephrine infusion (P=0.036).
• Phenylephrine significantly increased mean arterial pressure and sinus cycle length.
• Increased VFT correlated with sinus cycle length prolongation (77% vs 20%).

Conclusions:

• Phenylephrine administration increases the ventricular fibrillation threshold in humans.
• This effect is likely mediated by baroreceptor reflex activation, modulating cardiac efferent activity.
• Findings suggest a potential therapeutic role for phenylephrine in enhancing defibrillation efficacy.